Furthermore, in vitro TLR4- reprogrammed myeloid lymphatic endothelial cell progenitors (M-LECPs), generated functional cells that integrated into LYVE1+ tumor lymphatics in murine breast cancer models (Volk-Draper et al., 2017). Here, LYVE1 is linked to breast cancer.